Objective: Our purpose was to evaluate the results of Vibrant Soundbridge (VSB) in conductive or mixed hearing loss. Materials and Methods: Twenty-five adult patients (29 ears) with a mixed or conductive hearing loss and various etiologies were included in this retrospective study. The preoperative ipsilateral pure tone average was 71 ± 3.0 dB, and the average bone conduction threshold was 42 ± 2.8 dB (n = 29). The transducer was placed on the long apophysis of the incus (n = 16), in the round window (n = 10) or on the stapes (n = 3). Results: No complications were noted. The bone conduction threshold remained unchanged. VSB was activated in all cases. The postoperative pure tone average without VSB was 63 ± 3.9 dB (n = 24) and with VSB in free-field condition 24 ± 2.1 dB (n = 22). Conclusions: VSB is safe and efficacious for auditory rehabilitation in conductive and mixed hearing losses.

Sterkers O, Boucarra D, Labassi S, Bebear JP, Dubreuil C, Frachet B, Fraysse B, Lavieille JP, Magnan J, Martin C, Truy E, Uziel A, Vaneecloo FM: A middle ear implant, the Symphonix Vibrant Soundbridge: retrospective study of the first 125 patients implanted in France. Otol Neurotol 2003;24:427–436.
Vincent C, Fraysse B, Lavieille JP, Truy E, Sterkers O, Vaneecloo FM: Longitudinal study on postoperative hearing thresholds with the Vibrant Soundbridge device. Eur Arch Otorhinolaryngol 2004;261:493–496.
Mosnier I, Sterkers O, Bouccara D, Labassi S, Bebear JP, Bordure P, Dubreuil C, Dumon T, Frachet B, Fraysse B, Lavieille JP, Magnan J, Martin C, Meyer B, Mondain M, Portmann D, Robier A, Schmerber S, Thomassin JM, Truy E, Uziel A, Vanecloo FM, Vincent C, Ferrary E: Benefit of the Vibrant Soundbridge device in patients implanted for 5 to 8 years. Ear Hear 2008;29:281–284.
Colletti V, Carner M, Colletti L: TORP versus round window implant for hearing restoration of patients with extensive ossicular chain defect. Acta Otolaryngol 2009;129:449–452.
Venail F, Lavieille JP, Meller R, Deveze A, Tardivet L, Magnan J: New perspectives for middle ear implants: first results in otosclerosis with mixed hearing loss. Laryngoscope 2007;117:552–555.
Frenzel H, Hanke F, Beltrame M, Steffen A, Schönweiler R, Wollenberg B: Application of the Vibrant Soundbridge to unilateral osseous atresia cases. Laryngoscope 2009;119:67–74.
Arnold A, Kompis M, Candreia C, Pfiffner F, Haeusler R, Stieger C: The floating mass transducer at the round window: direct transmission or bone conduction? Hear Res 2010;263:120–127.
Nakajima HH, Dong W, Olson ES, Rosowski JJ, Ravicz ME, Merchant SN: Evaluation of round window stimulation using the floating mass transducer by intracochlear sound pressure measurements in human temporal bones. Otol Neurotol 2010;31:506–511.
Bruschini L, Forli F, Giannarelli M, Bruschini P, Berrettini S: Exclusive transcanal surgical approach for Vibrant Soundbridge implantation: surgical and functional results. Otol Neurotol 2009;30:950–955.
Foyt D, Carfrae M: Minimal access surgery for sympohonix/Med-El Vibrant Soundbridge middle ear implant. Otol Neurotol 2006;27:167–171.
Beltrame AM, Martini A, Prosser S, Giarbini N, Streitberger C: Coupling the Vibrant Soundbridge to cochlea round window: auditory results in patients with mixed hearing loss. Otol Neurotol 2009;30:194–201.
Streitberger C, Perotti M, Beltrame MA, Giarbini N: Vibrant Soundbridge for hearing restoration after chronic ear surgery. Rev Laryngol Otol Rhinol (Bord) 2009;130:83–88.
Dumon T, Gratacap B, Firmin F, Vincent R, Pialoux R, Casse B, Firmin B: Vibrant Soundbridge middle ear implant in mixed hearing loss: indications, techniques, results. Rev Laryngol Otol Rhinol (Bord) 2009;130:75–81.
Pau HW, Just T: Third window vibroplasty: an alternative in surgical treatment of tympanosclerotic obliteration of the oval and round window niche. Otol Neurotol 2010;31:225–227.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.